×
Entrez Id:
22853
Gene Symbol:
LMTK2
LMTK2
0.140
GeneticVariation
disease
GWASCAT
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.
29892016
2018
×
Entrez Id:
22853
Gene Symbol:
LMTK2
LMTK2
0.140
Biomarker
disease
BEFREE
Across 66 meta-analyses, a total of 20 genetic variants involving 584,100 subjects in 19 different genes (KLK3, IGFBP3, ESR1, SOD2, CAT, CYP1B1, VDR, RFX6, HNF1B, SRD5A2, FGFR4, LEP, HOXB13, FAS, FOXP4, SLC22A3, LMTK2 , EHBP1 and MSMB) exhibited significant association with prostate cancer .
26967244
2016
×
Entrez Id:
22853
Gene Symbol:
LMTK2
LMTK2
0.140
Biomarker
disease
BEFREE
In addition, LMTK2 knockdown led to an increase in prostate cancer stem cell populations in LNCaP cells, indicative of increased tumorogenicity.
26008968
2015
×
Entrez Id:
22853
Gene Symbol:
LMTK2
LMTK2
0.140
GeneticVariation
disease
BEFREE
Alterations in LMTK2 , MSMB and HNF1B gene expression are associated with the development of prostate cancer .
20569440
2010
×
Entrez Id:
22853
Gene Symbol:
LMTK2
LMTK2
0.140
GeneticVariation
disease
GWASCAT
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
19767753
2009
×
Entrez Id:
22853
Gene Symbol:
LMTK2
LMTK2
0.140
Biomarker
disease
BEFREE
The MSMB and KLK2/3 genes may be useful for PCa screening, and the LMTK2 gene might provide a potential therapeutic target.
19050691
2009
×
Entrez Id:
22853
Gene Symbol:
LMTK2
LMTK2
0.140
GeneticVariation
disease
GWASCAT
Multiple newly identified loci associated with prostate cancer susceptibility.
18264097
2008